Leading science, pioneering therapies

News

  1. £0.9m Commercial collaboration to improve blood cell production from stem cells

    Apr 27

    CRM scientists have joined forces with Plasticell to secure £920,000 Biomedical Catalyst funding from Innovate UK.  

  2. New Collaboration to Accelerate Drug Discovery Using Stem Cell Technology

    Mar 6

    The MRC-Centre for Regenerative Medicine (MRC-CRM) and the University of Dundee have announced a new collaboration to encourage partnership with the pharmaceutical industry. 

  3. Blood study provides hope for stem cell therapy

    Feb 15

    CRM researchers have pinpointed a key enzyme that is vital for the production of all blood cells in the body.

  4. New opportunities for screening models in brain cancer

    Feb 14

    CRM scientists have been able to make precise genetic changes to mouse and human neuronal stem cells for the first time.  This opens up the possibility for the study of the genetic changes seen in glioblastoma, the most common form of brain cancer.

  5. New clues to cause of bile duct cancer

    Oct 11

    Scientists at the CRM have identified a molecule that drives the development of bile duct cancer.  The research in mice and human cells sheds new light on what triggers the disease and how the illness progresses.

  6. New insights into blood cancer that develops before birth

    Jul 7

    Researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh have identified the cells responsible for a form of leukaemia that can develop while a baby is in the womb. 

  7. Edinburgh scientists to get £3.7million CRUK funding for cutting edge cancer research

    May 13

    Edinburgh scientists are set to receive a major cash boost from Cancer Research UK which could help to develop groundbreaking new brain tumour treatments.

  8. £1.8M for novel synthetic factors to improve iPS technology

    May 6

    Dr Abdenour Soufi, a Chancellor’s fellow and junior group leader at the MRC Centre for Regenerative Medicine (CRM), received a prestigious Medical Research Council (MRC) Career Development Award (CDA) earlier today.

  9. Using cellular components to treat drug overdose

    Apr 7

    It may be possible to treat paracetamol overdose in the future using microRNAs to silence transcription of genes that lead to the production of toxic metabolites. This is according to a proof-of-concept study carried out using stem cell models by researchers at the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh.

  10. Blood stem cells study could pave the way for new cancer therapy

    Mar 10

    People with leukaemia could be helped by new research that sheds light on how the body produces its blood supply.

  11. Further understanding of molecular mechanisms underlying blood disorders

    Feb 26

    Blood stem cells are responsible for the production of blood and are crucial for treating patients suffering from diseases related to blood cancer. Researchers are exploring ways of generating blood stem cells in the laboratory, for example to overcome the shortage of matching blood stem cell donors.

  12. Facts and figures 2015

    Jan 8

    The MRC Centre for Regenerative Medicine (CRM) was established in 2008 with the aim to gain fundamental understanding of stem cells and regeneration and to use this knowledge to improve human health and provide leadership in training and public engagement.

  13. Stem Cells Young Investigator Award for Prof Kamil R Kranc

    Dec 18

  14. How signals tell cells what to become: progress towards cell replacement therapy for Diabetes

    Dec 17

    Dr Gillian Morrison joined the MRC Centre for Regenerative Medicine in 2014 to work on stem cells and Diabetes. More specifically, she is looking at ways to make beta cells from pluripotent stem cells.

  15. £4M to further understand reprogramming of cells

    Dec 15

    Dr Keisuke Kaji, researcher at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM), has been awarded a £4M Fellowship Award by the Medical Research Council.

  16. Cancer study identifies genes that stop onset of leukaemia

    Dec 7

    Genes that act as brakes to stop the development of an aggressive form of leukaemia have been identified by researchers. Their findings offer fresh insights into how to tackle the disease and could lead to new therapies that prevent relapses.

  17. New Director

    Dec 1

    Prof Stuart Forbes has been appointed as new Director of the MRC Centre for Regenerative Medicine (CRM) at the University of Edinburgh.

  18. Stem cell study paves the way for patient therapies

    Nov 26

    Stem cells that have been specifically developed for use as clinical therapies are fit for use in patients, an independent study of their genetic make-up suggests. The research – which focused on human embryonic stem cells – paves the way for clinical trials of cell therapies to treat conditions such as Parkinson’s disease, age-related degeneration of the eyes and spinal cord injury.

  19. Liver cell therapies closer as study reveals key to mass production

    Nov 25

    Stem cell scientists have made a key find that aids the quest to produce therapies for patients with liver damage. They have developed a new technique for growing liver cells from stem cells that is cost-effective and could be adapted for mass production of clinical grade cells.

  20. Skin scent offers Parkinson’s hope

    Oct 22

    Researchers are to investigate whether Parkinson’s disease can be diagnosed from skin swabs.

Pages